Increased CD127+ and decreased CD57+ T cell expression levels in HIV-infected patients on NRTI-sparing regimens.

about

Improved CD4 T cell profile in HIV-infected subjects on maraviroc-containing therapy is associated with better responsiveness to HBV vaccination

P2860

Q58694800-581D0A7F-A134-4C4A-89C6-817821BBB0A3

P2860

Increased CD127+ and decreased CD57+ T cell expression levels in HIV-infected patients on NRTI-sparing regimens.

Item

http://www.wikidata.org/entity/Q47562735

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Increased CD127+ and decreased ...... ents on NRTI-sparing regimens.

@en

Increased CD127+ and decreased ...... ents on NRTI-sparing regimens.

@nl

type

Item

label

Increased CD127+ and decreased ...... ents on NRTI-sparing regimens.

@en

Increased CD127+ and decreased ...... ents on NRTI-sparing regimens.

@nl

prefLabel

Increased CD127+ and decreased ...... ents on NRTI-sparing regimens.

@en

Increased CD127+ and decreased ...... ents on NRTI-sparing regimens.

@nl

P1476

Increased CD127+ and decreased ...... ents on NRTI-sparing regimens.

@en

P2093

B Dominguez-Molina

http://www.w3.org/2001/XMLSchema#string

L Tarancon-Diez

http://www.w3.org/2001/XMLSchema#string

M Leal

http://www.w3.org/2001/XMLSchema#string

S Ferrando-Martinez

http://www.w3.org/2001/XMLSchema#string

P2860

Life expectancy of recently diagnosed asymptomatic HIV-infected patients approaches that of uninfected individuals

The Spanish HIV BioBank: a model of cooperative HIV research

In vitro and ex vivo inhibition of human telomerase by anti-HIV nucleoside reverse transcriptase inhibitors (NRTIs) but not by non-NRTIs

HIV infection, inflammation, immunosenescence, and aging.

Less Bone Loss With Maraviroc- Versus Tenofovir-Containing Antiretroviral Therapy in the AIDS Clinical Trials Group A5303 Study.

Temporal trends in the discontinuation of first-line antiretroviral therapy

Effect of maraviroc on HIV disease progression-related biomarkers.

Inflammation Perturbs the IL-7 Axis, Promoting Senescence and Exhaustion that Broadly Characterize Immune Failure in Treated HIV Infection.

Switching to Tenofovir Alafenamide, Coformulated With Elvitegravir, Cobicistat, and Emtricitabine, in HIV-Infected Patients With Renal Impairment: 48-Week Results From a Single-Arm, Multicenter, Open-Label Phase 3 Study

Once-daily maraviroc versus tenofovir/emtricitabine each combined with darunavir/ritonavir for initial HIV-1 treatment.

P2888

s12967-017-1367-5

P304

259

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12967-017-1367-5

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ezequiel Ruiz-Mateos

Mª Ángeles Muñoz-Fernández

Rebeca S De Pablo-Bernal

A Gonzalez-Serna

J L Jiménez

P577

2017-12-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1099732997

http://www.w3.org/2001/XMLSchema#string

P698

29262860

http://www.w3.org/2001/XMLSchema#string

P932

5738860

http://www.w3.org/2001/XMLSchema#string

Increased CD127+ and decreased CD57+ T cell expression levels in HIV-infected patients on NRTI-sparing regimens.

about

P2860

P2860

Increased CD127+ and decreased CD57+ T cell expression levels in HIV-infected patients on NRTI-sparing regimens.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P932